A novel method to delivery stem cells to the injured heart: Spatially focused magnetic targeting strategy

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 6, 2012, Pages 1203-1205

  Huang, Zheyong ^a   Pei, Ning ^b   Shen, Yunli ^a   Gong, Yongyong ^b   Xie, Xinxing ^a   Sun, Xiaoning ^a   Zou, Yunzeng ^a   Qian, Juying ^a   Sun, Aijun ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HEART; HEART INJURY; HUMAN; LETTER; MAGNETISM; METHODOLOGY; STEM CELL;

ANIMALS; HEART; HEART INJURIES; HUMANS; MAGNETICS; STEM CELLS;

EID: 84861553122     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01581.x     Document Type: Letter

References (24)

1. Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012; 2: CD006536.
2. Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006; 27: 1114-22.
3. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005; 111: 2198-202.
4. Penicka M, Widimsky P, Kobylka P, et al. Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation. 2005; 112: e63-5.
5. Li SH, Lai TY, Sun Z, et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg. 2009; 137: 1225-33. e1221.
6. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol. 2008; 45: 514-22.
7. Singh JP. Enabling technologies for homing and engraftment of cells for therapeutic applications. JACC Cardiovasc Interv. 2009; 2: 803-4.
8. Rodriguez-Losada N, Garcia-Pinilla JM, Jimenez-Navarro MF, Gonzalez FJ. Endothelial progenitor cells in cell-based therapy for cardiovascular disease. Cell Mol Biol (Noisy-le-grand). 2008; 54: 11-23.
9. Wu Y Zhao RC. The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev. 2012; 8: 243-50.
10. Langer R. Drug delivery. Drugs on target. Science. 2001; 293: 58-9.
11. Kim JA, Lee HJ, Kang HJ Park TH. The targeting of endothelial progenitor cells to a specific location within a microfluidic channel using magnetic nanoparticles. Biomed Microdevices. 2009; 11: 287-96.
12. Pislaru SV, Harbuzariu A, Gulati R, et al. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol. 2006; 48: 1839-45.
13. Polyak B, Fishbein I, Chorny M, et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci USA. 2008; 105: 698-703.
14. Darton NJ, Hallmark B, Han X, et al. The in-flow capture of superparamagnetic nanoparticles for targeting therapeutics. Nanomedicine. 2008; 4: 19-29.
15. Kobayashi T, Ochi M, Yanada S, et al. A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy. 2008; 24: 69-76.
16. Kobayashi T, Ochi M, Yanada S, et al. Augmentation of degenerated human cartilage in vitro using magnetically labeled mesenchymal stem cells and an external magnetic device. Arthroscopy. 2009; 25: 1435-41.
17. Sugioka T, Ochi M, Yasunaga Y, et al. Accumulation of magnetically labeled rat mesenchymal stem cells using an external magnetic force, and their potential for bone regeneration. J Biomed Mater Res A. 2008; 85: 597-604.
18. Wilhelm C, Bal L, Smirnov P, et al. Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. Biomaterials. 2007; 28: 3797-806.
19. Cheng K, Li TS, Malliaras K, et al. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res. 2010; 106: 1570-81.
20. Chaudeurge A, Wilhelm C, Chen-Tournoux A, et al. Can magnetic targeting of magnetically labeled circulating cells optimize ntramyocardial cell retention? Cell Transplant. 2011; DOI: http://dx.doi.org/10.3727/096368911x612440.
21. Cheng K, Malliaras K, Li TS, et al. Magnetic enhancement of cell retention, engraftment and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 2012; DOI: http://dx.doi.org/10.3727/096368911x627381.
22. Pei N, Huang ZY, Ge JB Zheng WL. In vitro study of deep capture of paramagnetic particle for targeting. J Magn Magn Mater. 2009; 321: 2911-5.
23. Huang Z, Pei N, Wang Y, et al. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials. 2010; 31: 2130-40.
24. Forest VF, Tirouvanziam AM, Perigaud C, et al. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Res Ther. 2010; 1: 4.